No Data
No Data
Returns On Capital Are Showing Encouraging Signs At Medprin Regenerative Medical Technologies (SZSE:301033)
Mai Pu Medical (301033.SZ) subsidiary obtained EU MDR certification for three products.
Meipu Medical (301033.SZ) announced that its subsidiary, Meipu Biotechnology (Germany) Co., Ltd., has three products...
Medprin Regenerative Medical Technologies: Half-year report for the year 2024.
Medprin Regenerative Medical Technologies: Summary of Half-Year Report in 2024.
Map Medical (301033.SZ): Currently, the company focuses on the field of neurosurgery.
On August 13th, Gelunhui reported that Maipu Medical (301033.SZ) stated on the investor interaction platform that their skull and facial repair system is one of the few products in China based on PEEK material and used for repairing skull and facial defects. The product combines precision processing equipment to prepare PEEK material into structures with dimensions, curvature, and thickness that fit the patient's real skull defect, with elastic modulus similar to human bone, good biocompatibility and stability, and resistance to creep and other properties. The company is currently focused on the field of neurosurgery.
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
No Data
No Data